FDA-approved drug may block resistance to anti-angiogenesis therapy

(Massachusetts General Hospital) A Massachusetts General Hospital research team has identified a potential strategy for improving the efficacy of angiogenesis inhibitors, drugs that help fight cancer by blocking the formation of new blood vessels.